OZON - Hot Stocks: ABUS sues MRNA; NLSN earnings; OZON drops on sanctions; FL downgrades
Headlines related to Ukraine remained the main fodder for trading in Monday's pre-market period. However, corporate news still drove the action in many individual stocks, with a lawsuit related to COVID vaccines presenting one of the biggest stories. Arbutus (NASDAQ:ABUS) jumped before the opening bell after filing a patent lawsuit against COVID vaccine maker Moderna (NASDAQ:MRNA). In other news, Nielsen (NYSE:NLSN) received a boost from the release of quarterly results. Turning to some of the morning's biggest decliners, Ozon Holdings (NASDAQ:OZON) plummeted on the impact of sanctions against Russia. Foot Locker (NYSE:FL) also lost ground, weighed down by a negative reaction to a strategy shift at the company. Gainers Arbutus (ABUS) rallied more than 10% in pre-market action after it filed a lawsuit against Moderna (MRNA), alleging patent violations related to MRNA's COVID vaccine. The lawsuit, which includes Genevant Sciences as a plaintiff, does not seek to block the manufacture
For further details see:
Hot Stocks: ABUS sues MRNA; NLSN earnings; OZON drops on sanctions; FL downgrades